EUCTR2017-002485-40-IT进行中（未招募）1 期
TREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT) - REBOOT
CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III0 个研究点目标入组 8,468 人开始时间: 2021年1月15日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 8,468
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) > 18 years old or 18 years old
- •2) STEMI or STEMI patient
- •3) LVEF >40%
- •4) INFORM CONSENT SIGNED
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 2000
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 6468
排除标准
- •1) Known allergy or intolerance to beta-blockers
- •2) Absolute contraindication to beta-blocker therapy according to treating physician judge
- •3) Prior history of HF, Killip class on admission or during hospitalization = II
- •4) Severe valvular heart disease (> 3+ for aortic or mitral insufficiency, aortic or mitral valve area =1.0 cm2).
- •5) Any condition (appart from AMI) that requires beta-blocker prescription on discharge according to treating physician judge
- •6) Any medical condition that, in the investigator´s judgment, would seriously limit life expectancy (less than one year),
- •7) Patients participating in other clinical trials.
研究者
相似试验
进行中（未招募）
1 期
BETAMI studien: Behandling med eller uten betablokkere hos pasientermed hjerteinfarktPatients admitted to hospital with acute myocardial infarction treated With reperfusion therapy (i.e trombolysis or percutaneous coronary intervention)EUCTR2018-000590-75-NOOslo University Hospital5,000
已完成
4 期
TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"Myocardial InfarctionNCT03596385Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III8,505
进行中（未招募）
1 期
Danish trial of beta blocker treatment after myocardial infarction without signs of heart failure (DANBLOCK)MedDRA version: 20.0Level: LLTClassification code 10028595Term: Myocardial infarctSystem Organ Class: 10007541 - Cardiac disordersMyocardial infarction. We wish to test whether long-term treatment with betablocker (bisoprolol, carvedilol, metoprolol or nebivolol) leads to better prognosis than no treatment in patients suffering a myocardial infarction who do not have signs of heart failureEUCTR2018-002699-42-DKBispebjerg Frederiksberg Hospital2,760
进行中（未招募）
4 期
BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic FunctionNon-ST Elevation Myocardial InfarctionST Elevation Myocardial InfarctionAcute Myocardial InfarctionNCT03646357Oslo University Hospital2,895
进行中（未招募）
1 期
Evaluation of Beta Blockers for the Treatment of Asthma. A randomised controlled trial of propranolol.MedDRA version: 12.1Level: LLTClassification code 10003553Term: AsthmaasthmaEUCTR2009-017356-28-GBniversity of Dundee15